Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-038643
Filing Date
2021-10-01
Accepted
2021-10-01 17:00:35
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4124
  Complete submission text file 0000899243-21-038643.txt   6233
Mailing Address 60 WALL STREET NEW YORK NY 10005
Business Address 60 WALL STREET NEW YORK NY 10005 212-319-7600
Dainippon Sumitomo Pharma Co Ltd (Reporting) CIK: 0001446601 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 211299739

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27-1, SHINKAWA 2-CHOME CHUO-KU TOKYO M0 104-8260
Business Address 27-1, SHINKAWA 2-CHOME CHUO-KU TOKYO M0 104-8260 813-5543-5142
Sumitomo Chemical Co., Ltd. (Reporting) CIK: 0001798550 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 211299740